Maria Teresa Di Martino
Maria Teresa Di Martino
Verified email at
Cited by
Cited by
Mir-34: a new weapon against cancer?
G Misso, MT Di Martino, G De Rosa, AA Farooqi, A Lombardi, V Campani, ...
Molecular therapy-nucleic acids 3, e195, 2014
Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo EvidenceAntitumor Activity of miR-34a in Multiple Myeloma
MT Di Martino, E Leone, N Amodio, U Foresta, M Lionetti, MR Pitari, ...
Clinical cancer research 18 (22), 6260-6270, 2012
Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell GrowthAntitumor Activity of mir-21 Inhibitors in Multiple Myeloma
E Leone, E Morelli, MT Di Martino, N Amodio, U Foresta, A GullÓ, M Rossi, ...
Clinical Cancer Research 19 (8), 2096-2106, 2013
miR‐29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma‐related bone disease
M Rossi, MR Pitari, N Amodio, MT Di Martino, F Conforti, E Leone, C Botta, ...
Journal of cellular physiology 228 (7), 1506-1515, 2013
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1
N Amodio, MT Di Martino, U Foresta, E Leone, M Lionetti, M Leotta, ...
Cell death & disease 3 (11), e436-e436, 2012
DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma
N Amodio, M Leotta, D Bellizzi, MT Di Martino, P D'Aquila, M Lionetti, ...
Oncotarget 3 (10), 1246, 2012
In vitro and in vivo anti-tumor activity of miR-221/222 inhibitors in multiple myeloma
MT Di Martino, A GullÓ, MEG Cantafio, M Lionetti, E Leone, N Amodio, ...
Oncotarget 4 (2), 242, 2013
In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma
MT Di Martino, V Campani, G Misso, ME Gallo Cantafio, A Gulla, ...
PloS one 9 (2), e90005, 2014
A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells
T Calimeri, E Battista, F Conforti, P Neri, MT Di Martino, M Rossi, ...
Leukemia 25 (4), 707-711, 2011
Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivo
P Tassone, MT Di Martino, M Ventura, A Pietragalla, I Cucinotto, ...
Cancer biology & therapy 8 (7), 648-653, 2009
Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo
E Morelli, E Leone, ME Cantafio, MT Di Martino, N Amodio, L Biamonte, ...
Leukemia 29 (11), 2173-2183, 2015
Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity
L Raimondi, N Amodio, MT Di Martino, E Altomare, M Leotta, ...
Oncotarget 5 (10), 3039, 2014
miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells
N Amodio, D Bellizzi, M Leotta, L Raimondi, L Biamonte, P D’Aquila, ...
Cell Cycle 12 (23), 3650-3662, 2013
Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma
D Cosco, F Cilurzo, J Maiuolo, C Federico, MT Di Martino, MC Cristiano, ...
Scientific reports 5 (1), 1-11, 2015
Biological and Clinical Relevance of miRNA Expression Signatures in Primary Plasma Cell LeukemiamiRNA Expression in Primary Plasma Cell Leukemia
M Lionetti, P Musto, MT Di Martino, S Fabris, L Agnelli, K Todoerti, ...
Clinical cancer research 19 (12), 3130-3142, 2013
A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma CellsLNA-i-miR-221 Inhibitor Overcomes Melphalan Resistance
A GullÓ, MT Di Martino, ME Gallo Cantafio, E Morelli, N Amodio, C Botta, ...
Clinical cancer research 22 (5), 1222-1233, 2016
Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts
MR Pitari, M Rossi, N Amodio, C Botta, E Morelli, C Federico, A GullÓ, ...
Oncotarget 6 (29), 27343, 2015
A p53‐dependent tumor suppressor network is induced by selective miR‐125a‐5p inhibition in multiple myeloma cells
M Leotta, L Biamonte, L Raimondi, D Ronchetti, MT Di Martino, C Botta, ...
Journal of cellular physiology 229 (12), 2106-2116, 2014
Promises and challenges of MicroRNA-based treatment of multiple myeloma
P Tagliaferri, M Rossi, M T Di Martino, N Amodio, E Leone, A Gulla, A Neri, ...
Current cancer drug targets 12 (7), 838-846, 2012
Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: a DMETá…
MT Di Martino, M Arbitrio, E Leone, PH Guzzi, M Saveria Rotundo, ...
Cancer biology & therapy 12 (9), 780-787, 2011
The system can't perform the operation now. Try again later.
Articles 1–20